Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Inhibitors

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

Results 1 - 10 of 95 > >>
EC Number Inhibitors Commentary Structure
Show all pathways known for 3.2.1.33Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.331,4-diaminobutane putrescine, glycogen debranching enzyme, slight inhibition Go to the Ligand Summary Page
Show all pathways known for 3.2.1.33Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.331-deoxynojirimycin - Go to the Ligand Summary Page
Show all pathways known for 3.2.1.33Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.331-deoxynojirimycin in primary rat hepatocytes, the inhibition of glycogen breakdown reaches plateau at 100 microM with 25% inhibition and then remains unchanged Go to the Ligand Summary Page
Show all pathways known for 3.2.1.33Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.331-S-dimethylarsino-1-thio-beta-D-glucanopyranoside DATG, active site-directed irreversible inhibitor, inhibition: mechanism. Inactivation occurs with significant conformational change Go to the Ligand Summary Page
Show all pathways known for 3.2.1.33Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.331-S-dimethylarsino-1-thio-beta-D-glucanopyranoside DATG, active site-directed irreversible inhibitor, inhibition: mechanism. Inactivation occurs with significant conformational change; glycogen phosphorylase limit dextrin and Bis-Tris protect from inactivation Go to the Ligand Summary Page
Show all pathways known for 3.2.1.33Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.332,2-bis(hydroxymethyl)-2,2',2''-nitrilotriethanol Bis-Tris, reversible inhibitor Go to the Ligand Summary Page
Show all pathways known for 3.2.1.33Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.332,2-bis(hydroxymethyl)-2,2',2''-nitrilotriethanol 10 mM: 97% inhibition; Bis-Tris, reversible inhibitor Go to the Ligand Summary Page
Show all pathways known for 3.2.1.33Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.332,2-bis(hydroxymethyl)-2,2',2''-nitrilotriethanol Bis-Tris, reversible inhibitor; noncompetitive with glycogen phosphorylase limit dextrin, competitive with glucose Go to the Ligand Summary Page
Show all pathways known for 3.2.1.33Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.332,2-bis(hydroxymethyl)-2,2',2''-nitrilotriethanol - Go to the Ligand Summary Page
Show all pathways known for 3.2.1.33Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.332-(2-hydroxyethylamino)-2-hydroxymethyl-1,3-propanediol hydroxyethyltris Go to the Ligand Summary Page
Results 1 - 10 of 95 > >>